Adjacent vessel sign and breast imaging reporting and data system are valuable for diagnosis of benign and malignant breast lesions

References

• Aubard Y, Genet D, Eyraud JL, Clavère P, Tubiana-Mathieu N, Philippe HJ. Impact of screening on breast cancer detection. Retrospective comparative study of two periods ten years apart. Eur J Gynaecol Oncol. 2002;23:37–41.
   PubMed Web of Science ®Google Scholar
• Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging. 2001;13:889–895.
   PubMed Web of Science ®Google Scholar
• Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for non mass like enhancement. AJR Am J Roentgenol. 2009;193:994–1000.
   PubMed Web of Science ®Google Scholar
• Malich A, Fischer DR, Wurdinger S, Boettcher J, Marx C, Facius M, Kaiser WA. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol. 2005;185:964–970.
   PubMed Web of Science ®Google Scholar
• Peters NH, BorelRinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116–124.
   PubMed Web of Science ®Google Scholar
• Kim do Y, Moon WK, Cho N, Ko ES, Yang SK, Park JS, Kim SM, Park IA, Cha JH, Lee EH. MRI of breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol. 2007;8:32–39.
   PubMedGoogle Scholar
• Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, Sakai S, Hatakenaka M, Kubo M, Sadanaga N, Yamamoto H, Honda H. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging. 2008;28:1157–1165.
   PubMed Web of Science ®Google Scholar
• Thomas MA, Lipnick S, Velan SS, Liu X, Banakar S, Binesh N, Ramadan S, Ambrosio A, Raylman RR, Sayre J, DeBruhl N, Bassett L. Investigation of breast cancer using two-dimensional MRS. NMR Biomed 2009;22:77–91.
   PubMed Web of Science ®Google Scholar
• Williams TC, DeMartini WB, Partridge SC, Peacock S, Lehaman CD. Breast MR imaging: computer-aided program for discriminating benign from malignant lesion. Radiology. 2007;244:94–103.
   PubMed Web of Science ®Google Scholar
• Sardanelli F, Fausto A, Menicagli L, Esseridou A. Breast vascular mapping obtained with contrast-enhanced MR imaging: implications for cancer diagnosis, treatment, and risk stratification. Eur Radiol. 2007;17:48–51.
   Google Scholar
• Mahfouz AE, Sherif H, Saad A, Taupitz M, Filimonow S, Kivelitz D, Hamm B. Gadolinimun-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vasularity? Eur Radiol. 2001;11:965–969.
   PubMed Web of Science ®Google Scholar
• Carriero A, Di Credico A, Mansour M, Bonomo L. Maximum intensity projection analysis inmagnetic resonance of the breast. J Exp Clin Cancer Res. 2002;21:77–81.
   PubMed Web of Science ®Google Scholar
• Sardanelli F, Iozzelli A, Fausto A, Fausto A, Kirchin MA. Gadobenatedimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology. 2005;235:791–797.
   PubMed Web of Science ®Google Scholar
• Wright H, Listinsky J, Quinn C, Rim A, Crowe J, Kim J. Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer. Am J Surg. 2005;190:576–579.
   PubMed Web of Science ®Google Scholar
• Schmitz AC, Peters NH, Veldhuis WB, Gallardo AM, van Diest PJ, Stapper G, van Hillegersberg R, Mali WP, van den Bosch MA. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol. 2008;18:355–364.
   PubMed Web of Science ®Google Scholar
• Kang DK, Kim HS, Sun JS, Jung YS. Correlation of whole-breast vascularity with ipsilateral breast cancers using contrast-enhanced MDCT. AJR Am J Roentgenol. 2008;190:496–504.
   PubMed Web of Science ®Google Scholar
• Verardi N, Di Leo G, Carbonaro LA, Fedeli MP, Sardanelli F. Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients. Radiol Med. 2013;118:239–250.
   PubMed Web of Science ®Google Scholar
• Fischer DR, Wurdinger S, Boettcher J, Malich A, Kaiser WA. Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol. 2005;40:430–435.
   PubMed Web of Science ®Google Scholar
• Dietzel M, Baltzer PA, Vag T, Herzog A, Gajda M, Camara O, Kaiser WA. The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1084 histologically verified cases. Korean J Radiol. 2010;11:178–186.
   PubMed Web of Science ®Google Scholar
• Kul S, Cansu A, Alhan E, Dinc H, Reis A, Can G. Contrast-enhanced MR angiography of the breast: evaluation of ipsilateral increased vascularity and adjacent vessel sign in the characterization of breast lesions. AJR Am J Roentgenol. 2010;195:1250–1254.
   PubMed Web of Science ®Google Scholar
• Ham M, Kim TH, Kang DK, Kim KS, Yim H. Prognostic role of MRI enhancement features in patients with breast vancer: value of adjacent vessel sign and increased ipsilateral whole-breast vascularity. AJR Am J Roentgenol. 2012;199:921–928.
   PubMed Web of Science ®Google Scholar
• Tozaki M. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ. Breast Cancer 2013;20:13–20.
   PubMed Web of Science ®Google Scholar
• Tardivon AA, Athanasiou A, Thibault F, El Khoury C. Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol. 2007;61:212–215.
   PubMed Web of Science ®Google Scholar
• Mussurakis S, Cibbs P, Horsman A. Peripheral enhancement and spatial contrast uptake heterogeneity of primary breast tumours: quantitative assessment with dynamic MRI. J Comput Assist Tomogr. 1998;22:35–46.
   PubMed Web of Science ®Google Scholar